Clinical Trials Browser

Approved for marketing × Glioma × 1 year × Clear all

NCT04617002 2025-08-20

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Approved for marketing

Glioma